According to Fu et al., the antitumor activity of CAR-exosomes is antigen-specific and mediated through CAR, as anti-EGFR and anti-Her2 CAR-exosomes effectively eliminate EGFR+ and Her2+ tumor cells [3]. Here, ERBB2 is linked to neoplasm.